Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
Australian and New Zealand Journal of Medicine
|
June 1, 1993
Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis
P K Li, T W Mak, K Chiu, et al.
Lupus
|
January 16, 2002
Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A
L S Tam, E K Li, C C Szeto, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 5, 2001
Recurrent IgA nephropathy in renal transplant allografts
A Y Wang, F M Lai, A W Yu, et al.
Journal of Internal Medicine
|
February 27, 2003
Extrapolation of reciprocal creatinine plot is not reliable in predicting the onset of dialysis in patients with progressive renal insufficiency
C-C Szeto, C-B Leung, T Y-H Wong, et al.
British Medical Journal (Clinical Research Ed.)
|
February 6, 1988
Parathyroid hormone as a causative factor of primary non-function in renal transplants
Z Varghese, J E Scoble, M K Chan, et al.
Kidney International
|
May 31, 2001
Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases
C C Szeto, K M Chow, C B Leung, et al.
The American Journal of Medicine
|
May 2, 2001
The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria
C C Szeto, F M Lai, K F To, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 1, 1995
The interaction of fluvastatin and cyclosporin A in renal transplant patients
P K Li, T W Mak, A Y Wang, et al.
Nephron
|
January 1, 1994
Circulating leukocyte-endothelial adhesion molecules in IgA nephropathy
K N Lai, K C Wong, P K Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 20, 1998
Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy
P K Li, K Tsang, C C Szeto, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
Australian and New Zealand Journal of Medicine
|
June 1, 1993
Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis
P K Li, T W Mak, K Chiu, et al.
Lupus
|
January 16, 2002
Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A
L S Tam, E K Li, C C Szeto, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 5, 2001
Recurrent IgA nephropathy in renal transplant allografts
A Y Wang, F M Lai, A W Yu, et al.
Journal of Internal Medicine
|
February 27, 2003
Extrapolation of reciprocal creatinine plot is not reliable in predicting the onset of dialysis in patients with progressive renal insufficiency
C-C Szeto, C-B Leung, T Y-H Wong, et al.
British Medical Journal (Clinical Research Ed.)
|
February 6, 1988
Parathyroid hormone as a causative factor of primary non-function in renal transplants
Z Varghese, J E Scoble, M K Chan, et al.
Kidney International
|
May 31, 2001
Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases
C C Szeto, K M Chow, C B Leung, et al.
The American Journal of Medicine
|
May 2, 2001
The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria
C C Szeto, F M Lai, K F To, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 1, 1995
The interaction of fluvastatin and cyclosporin A in renal transplant patients
P K Li, T W Mak, A Y Wang, et al.
Nephron
|
January 1, 1994
Circulating leukocyte-endothelial adhesion molecules in IgA nephropathy
K N Lai, K C Wong, P K Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 20, 1998
Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy
P K Li, K Tsang, C C Szeto, et al.
Page
of 9